MSD Archives - InnoHEALTH magazine

A Neo Diabetic’s Tryst with Destiny

InnoHEALTH Magazine — Fri, 14 Dec 2018 08:32:40 +0000

A Neo Diabetic’s Tryst with Destiny & Birth of Innovative Enterprise to Combat Challenge

Where there’s a will there’s a way. For a young man – Sachin Gaur, a medical urgency that too on an alien land sent things topsy-turvy for a while, but he envisioned latent prospect in the disgusting scenario. Soon after stepping out from the hospital, he summarily stitched an innovative group to combat challenges being faced by millions of diabetic patients globe over.

Astoundingly, strange are the ways of nature to lend you a helping hand in a well-intentioned initiative. On way back home from Hyderabad, Sachin shared the flight coincidentally with one of the key chemists working with MSD for the last 22 years. He is a Harvard alumnus and was part of the team which designed the molecule called Januvia, which is one of the key drugs for diabetes. The whole gambit of diabetes and afflicted persons were discussed threadbare on board.

[vc_single_image image=”5039″ img_size=”large” alignment=”center”]

It was Sachin Gaur’s tryst with destiny – narration of the sugary tale. “My quest for diabetes cure and management: a health accident that has given me a purpose in life.

Surrounded by healthcare experts, my quest of promoting healthcare innovations could not have been better. Until I was diagnosed with high blood sugar and the week immediately after with a medical emergency, which has no direct link with my diabetic condition, but the treatment is such that I need to have a strict regime of a brisk walk, frequent meals, and schedule of oral drugs and insulin. As I am writing this I have spent 6 days in a hospital bed (which was the first time since I was born) and 14 days out of it. The condition I had, essentially, I felt reborn but this time it seemed with a greater purpose. So, I am writing this article – not as 35 years old but a 20-day infant.

It seems the drugs that I am taking have made me as curious as a child – nothing seems impossible. I was able to synthesize a few lines on the hospital bed, which summarize my state of the mind. For English readers, this poem essentially means that I want to win my diet, in my mind and the exercise that this body can do. I need a resolve, determination, and courage from the almighty combined with the blessings of my elders and love of dear ones to defeat the voices of the world.

With this thought process in my mind, the project “Experiments with Sugar” (www.ExperimentsWithSugar.in) was born. With a team of 11 – from different walks of life: medical experts, researchers, a filmmaker, and more joining every day; we aim to enable 1 million people living with diabetes either cure or better manage their diabetes by the end of September 2021. I will be reporting the progress to you for the next three years via the InnoHEALTH magazine. This is the first social cause project we have undertaken at “InnovatioCuris Foundation for Healthcare and Excellence” (ICFHE), a not-for-profit organization as a mission mode project.

With the support of our experts, I managed to meet with some of the top experts and we are getting a great response. To name a few: Dr. Rakesh Sahay, Head of Department at Osmania Medical College; Joseph Duffy, Executive Director, Head of A Neo Diabetic’s Tryst with Destiny & Birth of Innovative Enterprise to Combat Challenge External Discovery Chemistry – Kenilworth, Merck & Co.

We plan to release a few episodes every month as a web series to provide scientifically correct information but in an accessible way to the common man. So, as a reader do guide us and send good suggestions our way. By the year-end, we also aim to produce a very high-quality report on the unmet needs of the stakeholders involved in the life of a person living with diabetes. This will then feed into the Smart India Hackathon planned in February 2019 as a diabetes track to support innovation in the country. We need suggestions for a planned roundtable in December 2018 in Hyderabad to validate our findings and further record the proceedings on the best scientific knowledge on diabetes.

Please write to me by sending an email with a suggestion and queries at sachin@innovatiocuris.com.

The post A Neo Diabetic’s Tryst with Destiny appeared first on InnoHEALTH magazine.

Beactica, BluSense Diagnostics and Optomed announced as winners of the prestigious Nordic Stars 2018 Award at NLSDays in Stockholm

InnoHEALTH Magazine — Thu, 13 Sep 2018 05:23:59 +0000

Stockholm, September 12, 2017. Beactica, BluSense Diagnostics and Optomed are the recipients of the Nordic Stars 2018 Award. The highly coveted award was presented to the winners from three Nordic countries at the conclusion of the Nordic Life Science Days (NLSDays) in Stockholm. Growing numbers of one-on-one meetings and licensing opportunities year by year to a new all-time high underpin that the conference has become an established arena for high quality meetings between, companies, service providers, investors, research communities, and government and regulatory bodies. Approximately 1,280 delegates representing almost 800 companies from 40 countries joined the conference, thus confirming NLSDays’ role as the premier Nordic life sciences event.

Nordic Stars Award were introduced in 2013 in special recognition of life science companies in the Nordic region demonstrating outstanding innovation and entrepreneurial skills.

Björn Ursing, Chairman of the Nordic Stars Award commented:

“At SwedenBIO we are proud to present the three winners of the Nordic Stars Award 2018. Each of them constitutes an excellent example of how companies from the Nordics succeed in developing solutions that can contribute to better healthcare globally.”

This year’s winners are:

Beactica

Beactica has through a series of EU-grants and discovery collaborations with several global pharmaceutical companies proved to be a trusted partner in fragment-based lead generation. They have also used their proprietary methodologies to pursue their own drug discovery programs in oncology, attracting widespread interest from both investors and international pharma companies.

http://www.beactica.com/
BluSense Diagnostics

BluSense Diagnostics has developed an innovative point-of-care platform for accurate, portable and affordable infectious disease diagnostics. With a grant from European Innovation Council pilot (EIC pilot) and CE-marking for their reader and the first diagnostic test for acute dengue fever, they are now on the verge of a market launch, less than four years after incorporation.

https://www.blusense-diagnostics.com/
Optomed

Optomed has made fundus screening readily available and affordable for even small practices. Their devices in combination with AI-based software have enhanced detection of diabetic retinopathy. In addition to having a medical device filling specific needs, they have been successful in commercialization, making it available to patients worldwide.

https://www.optomed.com/

High resolution picture of the winners will be uploaded to My Newsdesk soonest possible after the award ceremony. Scroll down to the bottom, see “Relaterat / Bilder & Videor”.

Jonas Ekstrand, Director General of SwedenBIO also reflected on the highly successful two days:

“Nordic Life Science Days with its unique atmosphere, has once again proved to be the premium conference, partnering and networking event within life science in Northern Europe. Join us next year again when the conference takes place in Malmö in the south of Sweden.”

Nordic Life Science Days 2018 in brief

Companies/Organizations: 780
Registered Delegates: 1280
Meeting requests: 14800
Meeting accepted: 2900
Partnering opportunities: 720

Malmö again next year

NLSDays will return to the south of Sweden in 2019. Join us next year in Malmö on September 10-12.

NLSDays

It is a SwedenBIO event, produced by Bionordic. NLSDays was founded in 2012 and has grown rapidly to become the largest Nordic partnering conference for the global life science industry.

Among the Big Pharma, investors and other major players registered for the meeting so far are AstraZeneca, MSD, Pfizer, Sanofi, SOBI, Boehringer Ingelheim, Roche, Bristol-Mayer Squibb, Bayer, Novo, Johnson & Johnson Innovation, GE Healthcare, DNB, Industrifonden, HealthCap, BioGeneration Ventures, Almi Invest, Gilde Healthcare, Gimv, Lundbeckfonden Ventures, Seventure Partners, IBM and IQVIA

In addition to partnering, NLSDays also offers an exhibition and a seminar program. Speakers include senior representatives from the global life science companies, investors, and academic leaders who will all share their expertise and views for the future.

www.nlsdays.com
About SwedenBIO

SwedenBIO who is the founder and organizer of the Nordic Life Science Days is the Swedish life science industry organization. Our nearly 200 members operate across all sub-sectors from pharmaceutical, biotechnology, medical technology to diagnostics. SwedenBIO serves to the benefit the entire life science industry in Sweden and is a member-driven, private, non-profit organization. The main objective is to improve the conditions for the life science industry for the benefit of industry growth and business development.

www.swedenbio.se

The post Beactica, BluSense Diagnostics and Optomed announced as winners of the prestigious Nordic Stars 2018 Award at NLSDays in Stockholm appeared first on InnoHEALTH magazine.